Given the FDAs prior position statement, however, and recent trend towards tightened oversight of GLP-1 compounding, future guidance is anticipated
Stimmeder, S., Leber, B., Sucher, R
A Minnesota physician is quoted in the report saying, I know that the FDA is going to approve this, and I thought, Why are we waiting? Because retatrutide has not completed the FDA approval process, products sold online or through clinics are black market drugs and come with no guarantee of quality, purity, or dosing accuracy
Me siento mucho ms energtico
Tirzepatide is the active ingredient in FDA-approved products marketed by other manufacturers
Again, were dealing with a lanyard here, not a single key, and I suspect that the magic of GLP-1 drugs is that theyre doing many things at once, some of which we wont understand for many years